David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
American Journal of Bioethics 2 (2):3 – 9 (2002)
The leading ethical position on placebo-controlled clinical trials is that whenever proven effective treatment exists for a given condition, it is unethical to test a new treatment for that condition against placebo. Invoking the principle of clinical equipoise, opponents of placebo-controlled trials in the face of proven effective treatment argue that they (1) violate the therapeutic obligation of physicians to offer optimal medical care and (2) lack both scientific and clinical merit. We contend that both of these arguments are mistaken. Clinical equipoise provides erroneous ethical guidance in the case of placebo-controlled trials, because it ignores the ethically relevant distinction between clinical trials and treatment in the context of clinical medicine and the methodological limitations of active-controlled trials. Placebo controls are ethically justifiable when they are supported by sound methodological considerations and their use does not expose research participants to excessive risks of harm.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Jeremy Howick (2009). Questioning the Methodologic Superiority of 'Placebo' Over 'Active' Controlled Trials. American Journal of Bioethics 9 (9):34-48.
Christine Czoli, Michael Silva, Randi Zlotnik Shaul, Lori Agincourt-Canning, Christy Simpson, Katherine Boydell, Natalie Rashkovan & Sharon Vanin (2011). Accountability and Pediatric Physician-Researchers: Are Theoretical Models Compatible with Canadian Lived Experience? Philosophy, Ethics, and Humanities in Medicine 6 (1):15-.
Rosamond Rhodes & Daniel A. Moros (2010). Privacy Overkill. American Journal of Bioethics 10 (9):12-15.
Rieke van der Graaf & Johannes J. M. van Delden (2009). What is the Best Standard for the Standard of Care in Clinical Research? American Journal of Bioethics 9 (3):35 – 43.
Daniel A. Moros & Rosamond Rhodes (2010). Privacy Overkill. American Journal of Bioethics 10 (9):12-15.
Similar books and articles
Ernst A. Singer (2004). The Necessity and the Value of Placebo. Science and Engineering Ethics 10 (1):51-56.
Franklin G. Miller & Howard Brody (2007). Clinical Equipoise and the Incoherence of Research Ethics. Journal of Medicine and Philosophy 32 (2):151 – 165.
Jacek Spławiński & Jerzy Kuźniar (2004). Clinical Trials: Active Control Vs Placebo — What is Ethical? Science and Engineering Ethics 10 (1):73-79.
Thomas R. Weihrauch (2004). Placebo Treatment is Effective Differently in Different Diseases — but is It Also Harmless? A Brief Synopsis. Science and Engineering Ethics 10 (1):151-155.
Piotr Zaborowski & Adam Górski (2004). Informed Consent and the Use of Placebo in Poland: Ethical and Legal Aspects. Science and Engineering Ethics 10 (1):167-178.
Jeremy Sugarman (2004). Using Empirical Data to Inform the Ethical Evaluation of Placebo Controlled Trials. Science and Engineering Ethics 10 (1):29-35.
Olov Lindahl & Lars Lindwall (1982). Is All Therapy Just a Placebo Effect? Theoretical Medicine and Bioethics 3 (2):255-259.
James A. Anderson (2006). The Ethics and Science of Placebo-Controlled Trials: Assay Sensitivity and the Duhem-Quine Thesis. Journal of Medicine and Philosophy 31 (1):65 – 81.
Added to index2009-01-28
Total downloads39 ( #41,667 of 1,096,588 )
Recent downloads (6 months)2 ( #153,658 of 1,096,588 )
How can I increase my downloads?